Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis

about

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis

Item

http://www.wikidata.org/entity/Q59126137

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 29 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@en

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@nl

type

Item

label

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@en

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@nl

prefLabel

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@en

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@nl

P1476

Clinical effectiveness of rani ...... degeneration: a meta-analysis

@en

P2093

Canwei Zhang

http://www.w3.org/2001/XMLSchema#string

Luping Wang

http://www.w3.org/2001/XMLSchema#string

Rui Hua

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept

Prevalence of age-related macular degeneration in the United States

Ranibizumab for neovascular age-related macular degeneration

Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys

The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.

Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials.

Bringing it all together: Lancet-Cochrane collaborate on systematic reviews.

The burden of age-related macular degeneration: a value-based medicine analysis

P304

3625-3633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.2147/DDDT.S176021

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30464394

http://www.w3.org/2001/XMLSchema#string

P921

age related macular degeneration

P932

6211581

http://www.w3.org/2001/XMLSchema#string